Clinical trials
Observational Thyroid Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 4 |
| Tel-Aviv Sourasky Medical Center | 3 |
| Umraniye Education and Research Hospital | 2 |
| Aventura Hospital and Medical Center | 1 |
| Beijing Friendship Hospital | 1 |
| Belarusian State Medical University | 1 |
| Centre Georges Francois Leclerc | 1 |
| Dr. Lutfi Kirdar Kartal Training and Research Hospital | 1 |
| Far Eastern Memorial Hospital | 1 |
| Fifth Affiliated Hospital, Sun Yat-Sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 43 |
| Thyroid Nodule | 7 |
| Thyroid Cancer, Papillary | 5 |
| Breast Neoplasms | 3 |
| Carcinoma, Medullary | 2 |
| Lung Neoplasms | 2 |
| Thyroid Carcinoma, Anaplastic | 2 |
| Thyroid Diseases | 2 |
| Adenocarcinoma, Follicular | 1 |
| Anxiety Disorders | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.